Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMP1 | P13497 | 3/20 | 0.49 |
| ▸ | GNPAT | O15228 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 3/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | SELL | P14151 | 1/20 | 0.37 |
| ▸ | SELP | P16109 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 6/20 | 0.36 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21664134 | 1.00 | BMP1 (0.49) | BMP1GNPATDPP4DPP8DPP9 | |
| SCHEMBL30656951 | 0.98 | BMP1 (0.50) | BMP1GNPATDPP4DPP8DPP9 | |
| SCHEMBL31666010 | 0.85 | GNPAT (0.50) | GNPATENPEP | |
| SCHEMBL434311 | 0.85 | GNPAT (0.50) | GNPATENPEP | |
| SCHEMBL31665968 | 0.85 | GNPAT (0.50) | GNPATENPEP | |
| SCHEMBL23366194 | 0.85 | GNPAT (0.50) | GNPATENPEP | |
| SCHEMBL13059958 | 0.85 | GNPAT (0.50) | GNPATENPEP | |
| SCHEMBL22070155 | 0.85 | GNPAT (0.50) | GNPATENPEP | |
| SCHEMBL434271 | 0.85 | GNPAT (0.50) | GNPATENPEP | |
| SCHEMBL31666032 | 0.85 | GNPAT (0.50) | GNPATENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130029920-A1 | Metal Nanoparticles | BRIMBLE MARGARET A (NZ) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029920-A1 | Metal Nanoparticles | PSTPIP2, PCNP, ANPEP | BMP1 782/4885GNPAT 1707/4885DPP4 924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.